Perrigo Approved for Clobetasol Propionate Shampoo

Perrigo announced that it has received final FDA approval to launch Clobetasol Propionate Shampoo 0.05%, the generic version of Galderma's Clobex Shampoo 0.05%. 

Clobetasol Propionate Shampoo is indicated for the treatment of moderate to severe scalp psoriasis for patients >18 years. Clobetasol propionate is a topical corticosteroid used to reduce the itching and inflammation. Corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins.

Perrigo will begin shipment of this product immediately.

For more information call (866) 634-9120 or visit http://www.perrigo.com/.